ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,283,268 | -19.3% | 270,005 | -23.1% | 0.14% | -9.4% |
| Q2 2023 | $31,327,732 | +1662.2% | 351,011 | +2311.5% | 0.16% | +1500.0% |
| Q4 2022 | $1,777,724 | +140.2% | 14,556 | +191.1% | 0.01% | +400.0% |
| Q2 2020 | $740,000 | -34.3% | 5,000 | -50.0% | 0.00% | 0.0% |
| Q1 2020 | $1,126,000 | +47.2% | 10,000 | +81.8% | 0.00% | -33.3% |
| Q4 2019 | $765,000 | +13.5% | 5,500 | -21.4% | 0.00% | 0.0% |
| Q3 2019 | $674,000 | -16.4% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $806,000 | -19.4% | 7,000 | -17.6% | 0.00% | -25.0% |
| Q1 2019 | $1,000,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |